| 000 | 01853 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516011524.0 | ||
| 264 | 0 | _c20110224 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1365-2125 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.2010.03743.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDuran, Marta | |
| 245 | 0 | 0 |
_aPreliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cNov 2010 |
||
| 300 |
_a656-63 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiemetics _xpharmacokinetics |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCannabidiol _xpharmacokinetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aDronabinol _xanalogs & derivatives |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 700 | 1 | _aPérez, Eulàlia | |
| 700 | 1 | _aAbanades, Sergio | |
| 700 | 1 | _aVidal, Xavier | |
| 700 | 1 | _aSaura, Cristina | |
| 700 | 1 | _aMajem, Margarita | |
| 700 | 1 | _aArriola, Edurne | |
| 700 | 1 | _aRabanal, Manel | |
| 700 | 1 | _aPastor, Antoni | |
| 700 | 1 | _aFarré, Magí | |
| 700 | 1 | _aRams, Neus | |
| 700 | 1 | _aLaporte, Joan-Ramon | |
| 700 | 1 | _aCapellà, Dolors | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 70 _gno. 5 _gp. 656-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.2010.03743.x _zAvailable from publisher's website |
| 999 |
_c20339426 _d20339426 |
||